The Global Alliance for Chronic Diseases Supports 15 Major Studies in Hypertension Prevention and Control in Low- and Middle-Income Countries.

Sheldon W Tobe
DOI: https://doi.org/10.1111/jch.12835
Abstract:After the November 2007 Nature article on the grand challenges in chronic noncommunicable diseases (NCDs), the Global Alliance for Chronic Diseases (GACD) was formed in 2009 by six of the world’s largest public funders of health research. The first round of funding focused on hypertension, aligning with the World Health Organization’s (WHO’s) recognition that hypertension contributes to more deaths worldwide than any other single risk factor. The GACD funded 15 multiyear studies aimed at improving the awareness, prevention, treatment, and control of hypertension in lowand middle-income countries (LMICs) and in aboriginal communities in Canada. Several studies employ elements of the WHO’s Package of Essential Noncommunicable Disease Interventions for Primary Health Care in Low-Resource Settings (WHO PEN), which is a framework tool within the WHO NCD Global Action Plan 2013–2020. The studies are variously implementing and evaluating innovations in technology, health service delivery, policy changes, and patient engagement in order to identify costeffective implementation strategies to improve the
Medicine
What problem does this paper attempt to address?